Distinguished in Developmental Dysphasia Familial

Pierre Salmon-Krolak

Puteaux, FR 
Distinguished in Developmental Dysphasia Familial
Puteaux, FR 
OverviewLocationsClinical Research

Overview

Pierre Salmon-Krolak practices in Puteaux, France. Mr. Salmon-Krolak is rated as a Distinguished expert by MediFind in the treatment of Developmental Dysphasia Familial. His top areas of expertise are Dementia, Alzheimer's Disease, Developmental Dysphasia Familial, and Arterial Embolism.

His clinical research consists of co-authoring 174 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 29 articles in the study of Developmental Dysphasia Familial.

Gender
Male

Locations

Puteaux, France
Other Locations
Lyon, France
Villeurbanne, France
Bordeaux, France
Pierre-la-treiche, 69495, France
France
Bron, France
Saint-claude-de-diray, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Multicenter Randomized Superiority Study To Compare The Effects Of An 8-Weeks Mindfulness-based Intervention Versus Health Education Programme On Mental Health And Wellbeing In Individuals With Subjective Cognitive Decline
A Multicenter Randomized Superiority Study To Compare The Effects Of An 8-Weeks Mindfulness-based Intervention Versus Health Education Programme On Mental Health And Wellbeing In Individuals With Subjective Cognitive Decline
Enrollment Status: Completed
Publish Date: February 20, 2025
Intervention Type: Behavioral
Study Phase: Not Applicable
Episodic Specificity Induction: Research of Its Explanatory Mechanisms and Application to Normal and Pathological Ageing.
Episodic Specificity Induction: Research of Its Explanatory Mechanisms and Application to Normal and Pathological Ageing.
Enrollment Status: Completed
Publish Date: October 10, 2024
Predictive Value of Biomarkers of the Alzheimer's Disease (AD) in Elderly Patients With New-onset Epilepsy
Predictive Value of Biomarkers of the Alzheimer's Disease (AD) in Elderly Patients With New-onset Epilepsy
Enrollment Status: Completed
Publish Date: March 23, 2023
Intervention Type: Biological
Study Phase: Not Applicable
Longitudinal Study of Brain Amyloid imaGing in MEMENTO
Longitudinal Study of Brain Amyloid imaGing in MEMENTO
Enrollment Status: Completed
Publish Date: February 03, 2022
Intervention Type: Drug
Study Drugs: Flutemetamol, Florbetapir
Study Phase: Phase 3
MEMENTO-VAScular COmponents of Dementia
MEMENTO-VAScular COmponents of Dementia
Enrollment Status: Completed
Publish Date: January 28, 2022
Intervention Type: Other
Study Phase: Not Applicable
Functioning of the Mirror Neurons System in Parkinson's Disease and Its Impact on the Social Cognition
Functioning of the Mirror Neurons System in Parkinson's Disease and Its Impact on the Social Cognition
Enrollment Status: Completed
Publish Date: February 11, 2020
Intervention Type: Other
Study Phase: Not Applicable
A Randomized, Double-Blind, Delayed-Start Study of LY3314814 (AZD3293) in Early Alzheimer's Disease Dementia (Extension of Study AZES, The AMARANTH Study)
A Randomized, Double-Blind, Delayed-Start Study of LY3314814 (AZD3293) in Early Alzheimer's Disease Dementia (Extension of Study AZES, The AMARANTH Study)
Enrollment Status: Terminated
Publish Date: December 03, 2019
Intervention Type: Drug
Study Phase: Phase 3
CONFUCIUS Study : Impact of a Multifaceted Program to Prevent Postoperative Delirium in the Elderly
CONFUCIUS Study : Impact of a Multifaceted Program to Prevent Postoperative Delirium in the Elderly
Enrollment Status: Terminated
Publish Date: May 30, 2017
Intervention Type: Behavioral
Study Phase: Not Applicable
View 7 Less Clinical Trials

174 Total Publications

Faster decline of very prodromal dementia with Lewy bodies when amyloid positive.
Faster decline of very prodromal dementia with Lewy bodies when amyloid positive.
Journal: Alzheimer's & dementia (Amsterdam, Netherlands)
Published: February 07, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Salmon-Krolak's expertise for a condition
ConditionClose
    View All 13 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile